BGI News More
- BGI Genomics Announces Pricing of Initial Public Offering
- BGI Launches the Latest Desktop Sequencer BGISEQ-50
- International Science Community Welcomes China National GeneBank Opening
- BGI and Clearbridge BioMedics Partner to Develop China CTC Liquid Biopsy Market towards Precision Medicine
- The international Sc2.0 Project is on track to build the world’s first synthetic yeast genome
- Avian-specific conserved genomic elements play important regulatory roles in the macroevolution of avian-specific features
- The Evolution of Chronic Lymphocytic Leukemia Revealed
- BGI involved in publication of the first seahorse genome in Nature
- Leading Health Organizations in Canada and China Teaming up to Accelerate Precision Medicine
- World’s largest genomic organisation to collaborate with leading Queensland researchers
- Ranomics Partners with BGI to Classify Variants of Unknown Significance
- BGI and UW collaborate on precision medicine development
- Chinese innovation : BGI’s code for success
- Prof. Huanming Yang to Receive Membership from Royal Danish Academy of Sciences and Letters
- UW, Chinese genomics group forge new partnership to advance biomedical research
- Mapping more genomes will create a healthcare 'big data revolution'
Tel: +86-755-36307212Email: email@example.com
Celebration on the Founding of BGI Europe
Publish Date: 2010-05-11
On the May 17th 2010, 15:00 Denmark local time, the Sino-Danish Economic Cooperation Forum and the business contract signing ceremony was held in Copenhagen. With the co-witness of the Chinese Minister of Commerce Mr. Deming Chen and the Danish Minister of Economic Department of Commerce Mr. Brain Mikkelsen, Professor Songgang Li, the associated director of BGI, signed the business contract on behalf of BGI and officially announced the set up of BGI Europe in Copenhagen, Denmark.
The total registered capital of BGI Europe is 5 million DKK (about 860,000 USD). BGI plans to invest 10 million USD in Denmark in the first year and will recruit 20 to 50 local staff. Copenhagen, as headquarter of BGI-Europe, expects to establish a high-throughput sequencing platform within two years, to set up a production base in Europe and then outreach to all countries in Europe, collaborating research institutes and universities to establish joint labs in related areas. BGI-Europe will provide all European partners the opportunities in technology development, production design and project development, in fields of scientific research, agriculture and bioenergy, personal healthcare etc. The vision is to make BGI Europe one of the largest centers of sequencing and bioinformatics analysis in Europe.